Overview

A Study of Chinese Medicine Treating Depression

Status:
Unknown status
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
Chinese Medicine syndrome differentiation has been a prevalent therapy in China for thousands of years. It is based on patients' symptoms, pulse, tongue and coating on the tongue. Therefore, the syndrome of patients and corresponding Traditional Chinese Medicine (TCM) may vary. This multicenter prospective cohort studies the efficiency and safety of TCM compared with antidepressants. A total number of 4600 cases with primary depression are expected to be collected and divided into 3 cohorts based on the patients' requirement and choices. Patients in one group will receive TCM, and patients in the other two groups will respectively receive antidepressants only and integrated treatment of TCM and antidepressants. This study has 2 phases: treating period and the follow-up. The main purpose of this long-term study is to evaluate the efficiency of TCM compared with antidepressants in reducing relapse and suicide rate, changing lifestyle, improving patient compliance as well as the safety.
Details
Lead Sponsor:
The Third Affiliated Hospital of Beijing University of Chinese Medicine
Collaborators:
Beijing HuiLongGuan Hospital
Capital Medical University
First Affiliated Hospital of Heilongjiang Chinese Medicine University
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Shandong University of Traditional Chinese Medicine
The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Wu Xi Hospital of Traditional Chinese Medicine
Xiamen Hospital of Traditional Chinese Medicine
Treatments:
Antidepressive Agents